{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:30Z","timestamp":1792787970866,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82360468"],"award-info":[{"award-number":["82360468"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Hunan Provincial Science and Technology Department","award":["2024JJ7336"],"award-info":[{"award-number":["2024JJ7336"]}],"id":[{"id":"https:\/\/ror.org\/04qgr7x96","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04409-w","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:15:13Z","timestamp":1783116913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of Circ_0048766: an oncogenic circular rna promoting triple-negative breast cancer progression via the miR-329-3p\/CXCR4 axis and regulated by METTL3"],"prefix":"10.1186","volume":"26","author":[{"given":"Weihua","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"3","key":"4409_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4409_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fnmol.2018.00292","volume":"11","author":"I Lacal","year":"2018","unstructured":"Lacal I, Ventura R. Epigenetic Inheritance: Concepts, Mechanisms and Perspectives. Front Mol Neurosci. 2018;11:292.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"4409_CR3","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-024-02082-z","volume":"23","author":"W Zhang","year":"2024","unstructured":"Zhang W, Xu C, Yang Z, Zhou J, Peng W, Zhang X, Li H, Qu S, Tao K. Circular RNAs in tumor immunity and immunotherapy. Mol Cancer. 2024;23(1):171.","journal-title":"Mol Cancer"},{"issue":"16","key":"4409_CR4","doi-asserted-by":"publisher","first-page":"e100836","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, Wust S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16):e100836.","journal-title":"EMBO J"},{"issue":"11","key":"4409_CR5","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4409_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ijbiomac.2022.08.085","volume":"220","author":"SU Khan","year":"2022","unstructured":"Khan SU, Khan MU, Khan MI, Fadahunsi AA, Khan A, Gao S, Bilal M, Li F. Role of circular RNAs in disease progression and diagnosis of cancers: An overview of recent advanced insights. Int J Biol Macromol. 2022;220:973\u201384.","journal-title":"Int J Biol Macromol"},{"key":"4409_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-cellbio-120420-125117","volume":"38","author":"L Yang","year":"2022","unstructured":"Yang L, Wilusz JE, Chen LL. Biogenesis and Regulatory Roles of Circular RNAs. Annu Rev Cell Dev Biol. 2022;38:263\u201389.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4409_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cca.2021.09.013","volume":"523","author":"M Zhang","year":"2021","unstructured":"Zhang M, Bai X, Zeng X, Liu J, Liu F, Zhang Z. circRNA-miRNA-mRNA in breast cancer. Clin Chim Acta. 2021;523:120\u201330.","journal-title":"Clin Chim Acta"},{"issue":"9","key":"4409_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4409_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, Wu M. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94.","journal-title":"Mol Cancer"},{"issue":"4","key":"4409_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/epi-2019-0124","volume":"12","author":"SY Zhou","year":"2020","unstructured":"Zhou SY, Chen W, Yang SJ, Li J, Zhang JY, Zhang HD, Zhong SL, Tang JH. Circular RNA circVAPA regulates breast cancer cell migration and invasion via sponging miR-130a-5p. Epigenomics. 2020;12(4):303\u201317.","journal-title":"Epigenomics"},{"issue":"12","key":"4409_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jgg.2021.07.017","volume":"48","author":"F Chen","year":"2021","unstructured":"Chen F, Guo L, Di J, Li M, Dong D, Pei D. Circular RNA ubiquitin-associated protein 2 enhances autophagy and promotes colorectal cancer progression and metastasis via miR-582-5p\/FOXO1 signaling. J Genet Genomics. 2021;48(12):1091\u2013103.","journal-title":"J Genet Genomics"},{"issue":"1","key":"4409_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-021-01894-x","volume":"40","author":"X Zhou","year":"2021","unstructured":"Zhou X, Liu K, Cui J, Xiong J, Wu H, Peng T, Guo Y. Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p\/GOT1 axis in pancreatic cancer. J Exp Clin Cancer Res. 2021;40(1):124.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"4409_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41419-021-03565-3","volume":"12","author":"J Tang","year":"2021","unstructured":"Tang J, Zhang C, Huang Y, Wang L, Xu Z, Zhang D, Zhang Y, Peng W, Feng Y, Sun Y. CircRNA circ_0124554 blocked the ubiquitination of AKT promoting the skip lymphovascular invasion on hepatic metastasis in colorectal cancer. Cell Death Dis. 2021;12(3):270.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4409_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/1759-7714.13329","volume":"11","author":"Z Xu","year":"2020","unstructured":"Xu Z, Xiang W, Chen W, Sun Y, Qin F, Wei J, Yuan L, Zheng L, Li S. Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer. Thorac Cancer. 2020;11(4):875\u201387.","journal-title":"Thorac Cancer"},{"issue":"2","key":"4409_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.clbc.2022.11.004","volume":"23","author":"Z Chen","year":"2023","unstructured":"Chen Z, Gong X, Cheng C, Fu Y, Wu W, Luo Z. Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p\/AKAP12 Axis. Clin Breast Cancer. 2023;23(2):143\u201354.","journal-title":"Clin Breast Cancer"},{"key":"4409_CR17","doi-asserted-by":"crossref","unstructured":"Zan X, Li W, Wang G, Yuan J, Ai Y, Huang J, Li Z. Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p\/LDHA pathway. Reproductive biology and endocrinology: RB&E 2022, 20(1):138.","DOI":"10.1186\/s12958-022-00998-z"},{"issue":"1","key":"4409_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-022-01599-5","volume":"21","author":"L Meng","year":"2022","unstructured":"Meng L, Zhang Y, Wu P, Li D, Lu Y, Shen P, Yang T, Shi G, Chen Q, Yuan H, et al. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Mol Cancer. 2022;21(1):121.","journal-title":"Mol Cancer"},{"issue":"1","key":"4409_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0394632016686985","volume":"30","author":"LD Hou","year":"2017","unstructured":"Hou LD, Zhang J. Circular RNAs: An emerging type of RNA in cancer. Int J Immunopathol Pharmacol. 2017;30(1):1\u20136.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"4409_CR20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12885-018-4689-7","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Xie Q, He D, Ling Y, Li Y, Li J, Zhang H. Circular RNA: new star, new hope in cancer. BMC Cancer. 2018;18(1):834.","journal-title":"BMC Cancer"},{"issue":"1","key":"4409_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11427-023-2403-7","volume":"67","author":"H Zhu","year":"2024","unstructured":"Zhu H, Li T, Xu P, Ding L, Zhu X, Wang B, Tang X, Li J, Zhu P, Wang H, et al. Effect of autologous bone marrow stem cells-scaffold transplantation on the ongoing pregnancy rate in intrauterine adhesion women: a randomized, controlled trial. Sci China Life Sci. 2024;67(1):113\u201321.","journal-title":"Sci China Life Sci"},{"key":"4409_CR22","doi-asserted-by":"publisher","first-page":"121128","DOI":"10.1016\/j.lfs.2022.121128","volume":"312","author":"Q He","year":"2023","unstructured":"He Q, Hao Q, Wu Y, Vadgama JV, Jiang Y. CircRAD54L2 promotes triple-negative breast cancer progression by regulating the miR-888 family\/PDK1 axis. Life Sci. 2023;312:121128.","journal-title":"Life Sci"},{"key":"4409_CR23","doi-asserted-by":"publisher","first-page":"110494","DOI":"10.1016\/j.cellsig.2022.110494","volume":"101","author":"C Ji","year":"2023","unstructured":"Ji C, Zhu L, Fang L. Hsa_circ_0000851 promotes PDK1\/p-AKT-mediated cell proliferation and migration by regulating miR-1183 in triple-negative breast cancer. Cell Signal. 2023;101:110494.","journal-title":"Cell Signal"},{"issue":"8","key":"4409_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-024-07004-x","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang Y, Chen XQ, Jia YX, Ma J, Xu D, Xiang ZL. Circ-0044539 promotes lymph node metastasis of hepatocellular carcinoma through exosomal-miR-29a-3p. Cell Death Dis. 2024;15(8):630.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4409_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","volume":"15","author":"R Janssens","year":"2018","unstructured":"Janssens R, Struyf S, Proost P. The unique structural and functional features of CXCL12. Cell Mol Immunol. 2018;15(4):299\u2013311.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"4409_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41467-017-00728-9","volume":"8","author":"S Dushyanthen","year":"2017","unstructured":"Dushyanthen S, Teo ZL, Caramia F, Savas P, Mintoff CP, Virassamy B, Henderson MA, Luen SJ, Mansour M, Kershaw MH, et al. Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. Nat Commun. 2017;8(1):606.","journal-title":"Nat Commun"},{"issue":"1","key":"4409_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1541-7786.MCR-10-0235","volume":"9","author":"MA Chetram","year":"2011","unstructured":"Chetram MA, Odero-Marah V, Hinton CV. Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1\/2 in prostate cancer cells. Mol Cancer Res. 2011;9(1):90\u2013102.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"4409_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/FJC.0b013e318093ec8f","volume":"50","author":"H Zheng","year":"2007","unstructured":"Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha\/CXCR4 via PI3K\/Akt\/eNOS signal transduction pathway. J Cardiovasc Pharmacol. 2007;50(3):274\u201380.","journal-title":"J Cardiovasc Pharmacol"},{"key":"4409_CR29","doi-asserted-by":"publisher","first-page":"e925019","DOI":"10.12659\/MSM.925019","volume":"26","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Che X, Zhang S, Guo T, He X, Liu Y, Qu X. Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-kB)-Dependent Pathway. Med Sci Monit. 2020;26:e925019.","journal-title":"Med Sci Monit"},{"issue":"10","key":"4409_CR30","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1073\/pnas.1815515116","volume":"116","author":"IX Chen","year":"2019","unstructured":"Chen IX, Chauhan VP, Posada J, Ng MR, Wu MW, Adstamongkonkul P, Huang P, Lindeman N, Langer R, Jain RK. Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc Natl Acad Sci U S A. 2019;116(10):4558\u201366.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4409_CR31","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1096\/fj.201802067RR","volume":"33","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Li B, Liang Y, Reeves PM, Qu X, Ran C, Liu Q, Callahan MV, Sluder AE, Gelfand JA, et al. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB J. 2019;33(5):6596\u2013608.","journal-title":"FASEB J"},{"key":"4409_CR32","doi-asserted-by":"crossref","unstructured":"Wald O. CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC). J Clin Med 2018, 7(10):303.","DOI":"10.3390\/jcm7100303"},{"key":"4409_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2020.01.005","volume":"474","author":"D Wang","year":"2020","unstructured":"Wang D, Wang X, Si M, Yang J, Sun S, Wu H, Cui S, Qu X, Yu X. Exosome-encapsulated miRNAs contribute to CXCL12\/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Cancer Lett. 2020;474:36\u201352.","journal-title":"Cancer Lett"},{"issue":"3\u20134","key":"4409_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000339091","volume":"21","author":"Z Jiang","year":"2013","unstructured":"Jiang Z, Zhou W, Guan S, Wang J, Liang Y. Contribution of SDF-1alpha\/CXCR4 signaling to brain development and glioma progression. Neurosignals. 2013;21(3\u20134):240\u201358.","journal-title":"Neurosignals"},{"issue":"6","key":"4409_CR35","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","volume":"26","author":"B Bockorny","year":"2020","unstructured":"Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin BM, Stemmer SM, Golan T, Geva R, Borad MJ, Pedersen KS, et al. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat Med. 2020;26(6):878\u201385.","journal-title":"Nat Med"},{"issue":"1","key":"4409_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s13046-019-1461-z","volume":"38","author":"D Baci","year":"2019","unstructured":"Baci D, Bruno A, Cascini C, Gallazzi M, Mortara L, Sessa F, Pelosi G, Albini A, Noonan DM. Acetyl-L-Carnitine downregulates invasion (CXCR4\/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies. J Exp Clin Cancer Res. 2019;38(1):464.","journal-title":"J Exp Clin Cancer Res"},{"key":"4409_CR37","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.jbo.2019.100253","volume":"17","author":"TR Ullah","year":"2019","unstructured":"Ullah TR. The role of CXCR4 in multiple myeloma: Cells\u2019 journey from bone marrow to beyond. J Bone Oncol. 2019;17:100253.","journal-title":"J Bone Oncol"},{"issue":"3","key":"4409_CR38","doi-asserted-by":"publisher","first-page":"114","DOI":"10.55133\/eji.280312","volume":"28","author":"WT El-Sherif","year":"2021","unstructured":"El-Sherif WT, Salah El-Din EM, Aly MM, Said MG, Nigm DA. CXCR4 as a prognostic marker in Egyptian chronic lymphocytic leukemia patients. Egypt J Immunol. 2021;28(3):114\u201326.","journal-title":"Egypt J Immunol"},{"issue":"13","key":"4409_CR39","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1158\/1078-0432.CCR-12-3015","volume":"19","author":"K Beider","year":"2013","unstructured":"Beider K, Ribakovsky E, Abraham M, Wald H, Weiss L, Rosenberg E, Galun E, Avigdor A, Eizenberg O, Peled A, et al. Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140. Clin Cancer Res. 2013;19(13):3495\u2013507.","journal-title":"Clin Cancer Res"},{"key":"4409_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","volume":"124","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31\u201382.","journal-title":"Adv Cancer Res"},{"issue":"12","key":"4409_CR41","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1007\/s11095-014-1440-1","volume":"31","author":"Y Wang","year":"2014","unstructured":"Wang Y, Li J, Oupicky D. Polymeric Plerixafor: effect of PEGylation on CXCR4 antagonism, cancer cell invasion, and DNA transfection. Pharm Res. 2014;31(12):3538\u201348.","journal-title":"Pharm Res"},{"issue":"2","key":"4409_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1593\/tlo.12268","volume":"6","author":"D Heckmann","year":"2013","unstructured":"Heckmann D, Maier P, Laufs S, Wenz F, Zeller WJ, Fruehauf S, Allgayer H. CXCR4 Expression and Treatment with SDF-1alpha or Plerixafor Modulate Proliferation and Chemosensitivity of Colon Cancer Cells. Transl Oncol. 2013;6(2):124\u201332.","journal-title":"Transl Oncol"},{"issue":"43","key":"4409_CR43","doi-asserted-by":"publisher","first-page":"73387","DOI":"10.18632\/oncotarget.19945","volume":"8","author":"ID Weiss","year":"2017","unstructured":"Weiss ID, Huff LM, Evbuomwan MO, Xu X, Dang HD, Velez DS, Singh SP, Zhang HH, Gardina PJ, Lee JH, et al. Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET. Oncotarget. 2017;8(43):73387\u2013406.","journal-title":"Oncotarget"},{"issue":"5","key":"4409_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-0029-1237423","volume":"27","author":"C Dupont","year":"2009","unstructured":"Dupont C, Armant DR, Brenner CA. Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med. 2009;27(5):351\u20137.","journal-title":"Semin Reprod Med"},{"key":"4409_CR45","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.","journal-title":"Biomed Pharmacother"},{"issue":"26","key":"4409_CR46","doi-asserted-by":"publisher","first-page":"17697","DOI":"10.1016\/S0021-9258(17)32497-3","volume":"269","author":"JA Bokar","year":"1994","unstructured":"Bokar JA, Rath-Shambaugh ME, Ludwiczak R, Narayan P, Rottman F. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. J Biol Chem. 1994;269(26):17697\u2013704.","journal-title":"J Biol Chem"},{"key":"4409_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fonc.2020.00115","volume":"10","author":"DD Yang","year":"2020","unstructured":"Yang DD, Chen ZH, Yu K, Lu JH, Wu QN, Wang Y, Ju HQ, Xu RH, Liu ZX, Zeng ZL. METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway. Front Oncol. 2020;10:115.","journal-title":"Front Oncol"},{"key":"4409_CR48","doi-asserted-by":"publisher","first-page":"144076","DOI":"10.1016\/j.gene.2019.144076","volume":"722","author":"H Wang","year":"2020","unstructured":"Wang H, Xu B, Shi J. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene. 2020;722:144076.","journal-title":"Gene"},{"issue":"1","key":"4409_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","volume":"38","author":"W Peng","year":"2019","unstructured":"Peng W, Li J, Chen R, Gu Q, Yang P, Qian W, Ji D, Wang Q, Zhang Z, Tang J, et al. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246\/SPRED2\/MAPK signaling pathway. J Exp Clin Cancer Res. 2019;38(1):393.","journal-title":"J Exp Clin Cancer Res"},{"key":"4409_CR50","doi-asserted-by":"publisher","first-page":"173134","DOI":"10.1016\/j.ejphar.2020.173134","volume":"879","author":"Y Hu","year":"2020","unstructured":"Hu Y, Li Y, Huang Y, Jin Z, Wang C, Wang H, Xu J. METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B. Eur J Pharmacol. 2020;879:173134.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4409_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Mol Cancer. 2019;18(1):110.","journal-title":"Mol Cancer"},{"issue":"1","key":"4409_CR52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-019-1065-4","volume":"18","author":"B Yue","year":"2019","unstructured":"Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, Zhao G. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer. 2019;18(1):142.","journal-title":"Mol Cancer"},{"issue":"4","key":"4409_CR53","first-page":"3197","volume":"19","author":"S Liang","year":"2020","unstructured":"Liang S, Guan H, Lin X, Li N, Geng F, Li J. METTL3 serves an oncogenic role in human ovarian cancer cells partially via the AKT signaling pathway. Oncol Lett. 2020;19(4):3197\u2013204.","journal-title":"Oncol Lett"},{"issue":"1","key":"4409_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12672-025-02330-8","volume":"16","author":"B Wu","year":"2025","unstructured":"Wu B, Li D, Wang Y, Pan T, Xu J, Li L. The m6A methyltransferase METTL3 affects ferroptosis in non-small cell lung cancer by regulating the PTEN\/PI3K\/AKT pathway. Discover Oncol. 2025;16(1):559.","journal-title":"Discover Oncol"},{"issue":"3","key":"4409_CR55","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.gendis.2023.05.004","volume":"11","author":"Y Xu","year":"2024","unstructured":"Xu Y, Xu X, Zhang Q, Lu P, Xiang C, Zhang L, Lin C, Song Q. Gp130-dependent STAT3 activation in M-CSF-derived macrophages exaggerates tumor progression. Genes Dis. 2024;11(3):100985.","journal-title":"Genes Dis"},{"key":"4409_CR56","doi-asserted-by":"publisher","first-page":"111349","DOI":"10.1016\/j.cellsig.2024.111349","volume":"123","author":"X Li","year":"2024","unstructured":"Li X, Wang Y, Cheng J, Qiu L, Wang R, Zhang Y, Wang H. METTL3 -mediated m6A modification of circ_0000620 regulates cisplatin sensitivity and apoptosis in lung adenocarcinoma via the MiR-216b-5p\/KRAS axis. Cell Signal. 2024;123:111349.","journal-title":"Cell Signal"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04409-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04409-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04409-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:27:44Z","timestamp":1790288864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04409-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4409"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04409-w","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Ethics Committee of The Affiliated Tumor Hospital of Xinjiang Medical University (protocol code: G-2023010). The study is reported in accordance with ARRIVE guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"327"}}